HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,857 | -11.3% | 13,453 | -0.1% | 0.00% | – |
Q2 2023 | $15,622 | -14.6% | 13,467 | +11.2% | 0.00% | – |
Q1 2023 | $18,289 | -44.8% | 12,112 | -8.5% | 0.00% | – |
Q4 2022 | $33,105 | -31.0% | 13,242 | +16.7% | 0.00% | – |
Q3 2022 | $48,000 | +50.0% | 11,344 | -1.9% | 0.00% | – |
Q2 2022 | $32,000 | -67.7% | 11,562 | -33.3% | 0.00% | – |
Q1 2022 | $99,000 | -46.2% | 17,324 | -14.0% | 0.00% | – |
Q4 2021 | $184,000 | +44.9% | 20,146 | +70.2% | 0.00% | – |
Q3 2021 | $127,000 | -65.9% | 11,838 | -50.6% | 0.00% | -100.0% |
Q2 2021 | $372,000 | -2.1% | 23,968 | +2.4% | 0.00% | 0.0% |
Q1 2021 | $380,000 | -7.5% | 23,417 | +20.6% | 0.00% | -50.0% |
Q4 2020 | $411,000 | +158.5% | 19,415 | +80.7% | 0.00% | +100.0% |
Q3 2020 | $159,000 | -9.1% | 10,742 | -9.8% | 0.00% | 0.0% |
Q2 2020 | $175,000 | -34.7% | 11,910 | +4.5% | 0.00% | 0.0% |
Q4 2019 | $268,000 | +0.4% | 11,395 | +35.1% | 0.00% | -50.0% |
Q3 2018 | $267,000 | -18.1% | 8,432 | +0.3% | 0.00% | 0.0% |
Q2 2018 | $326,000 | – | 8,404 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |